ORAL ADMINISTRATION OF MRX0518 IN TREATMENTNAIVE CANCER PATIENTS IS ASSOCIATED WITH COMPOSITIONAL TAXONOMIC AND METABOLOMIC CHANGES INDICATIVE OF ANTI-TUMORIGENIC EFFICACY - Lythgoe, M; Mullish, B; Frampton, A; Dama, P; Pickford, E; Tookman, L; Cunnea, P; Fotopoulou, C; Jeffery, I; Fyvie, G; Stevenson, A; Krell, J (BMJ PUBLISHING GROUP, 2022)